Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc., a prominent player in the biotechnology sector, is headquartered in the United States. Founded in 2011, the company has established itself as a leader in advanced wound care and regenerative medicine, focusing on innovative solutions that enhance patient outcomes. Alliqua's core offerings include a range of proprietary products designed for wound management, such as hydrogel dressings and bioengineered tissue matrices. These products are distinguished by their unique formulations and effectiveness in promoting healing. With a strong market position, Alliqua BioMedical has achieved significant milestones, including strategic partnerships and product approvals that underscore its commitment to advancing healthcare. The company continues to expand its operational reach, serving healthcare providers across various regions in the US and beyond.
DitchCarbon Score
How does Alliqua BioMedical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alliqua BioMedical, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alliqua BioMedical, Inc.'s reported carbon emissions
Alliqua BioMedical, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete data, it is essential to note that many companies in the biomedical sector are increasingly focusing on sustainability and reducing their carbon footprints. Alliqua BioMedical may be expected to align with industry standards and practices in addressing climate change, although specific initiatives or commitments have not been disclosed at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alliqua BioMedical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
